These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9546754)

  • 21. Endocrine-disrupting chemicals probed as potential pathways to illness.
    Trubo R
    JAMA; 2005 Jul; 294(3):291-3. PubMed ID: 16030264
    [No Abstract]   [Full Text] [Related]  

  • 22. [Teratogenic effects of environmental lead exposure: a population case-control study].
    Vinceti M; Rovesti S; Calzolari E; Vivoli R; Astolfi G; Bergomi M
    Ann Ig; 2001; 13(2):129-38. PubMed ID: 11414102
    [No Abstract]   [Full Text] [Related]  

  • 23. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
    Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Looking for the fingerprint of a teratogen.
    Mekdeci B
    Birth Gaz; 1997; 13(4):47-8. PubMed ID: 9348802
    [No Abstract]   [Full Text] [Related]  

  • 25. Reproductive effects of herbicide exposure in Vietnam: recent studies by the Vietnamese and others.
    Constable JD; Hatch MC
    Teratog Carcinog Mutagen; 1985; 5(4):231-50. PubMed ID: 2866605
    [No Abstract]   [Full Text] [Related]  

  • 26. Maps of birth defects occurrence in the U.S., Birth Defects Monitoring Program (BDMP)/CPHA, 1970-1987.
    James LM
    Teratology; 1993 Dec; 48(6):551-646. PubMed ID: 8115972
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDT and urogenital malformations in newborn boys in a malarial area.
    Tren R; Roberts D; Maharaj R; Blumberg L; Hess K; Bate R; Urbach J; Attaran A
    BJU Int; 2010 Nov; 106(10):1556-8; author reply 1558-60. PubMed ID: 20977597
    [No Abstract]   [Full Text] [Related]  

  • 29. Population and case-control surveillance in the search for environmental causes of birth defects.
    Oakley GP
    Public Health Rep; 1984; 99(5):465-8. PubMed ID: 6207556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baby ills from beauty aids?
    Washam C
    Environ Health Perspect; 2001 May; 109(5):A202. PubMed ID: 11401772
    [No Abstract]   [Full Text] [Related]  

  • 32. Birth defect surveillance in the search for and evaluation of possible human teratogens.
    Oakley GP
    Birth Defects Orig Artic Ser; 1976; 12(5):1-6. PubMed ID: 953208
    [No Abstract]   [Full Text] [Related]  

  • 33. Exposures in pregnancy that are harmful to the fetus i.e. human teratogens.
    Holmes LB
    Pediatr Res; 1999 Feb; 45(2):286-7. PubMed ID: 10022604
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Birth malformations and other adverse perinatal outcomes": available data sources pose a dilemma.
    Kirby RS; Salihu HM
    Environ Health Perspect; 2003 Dec; 111(16):A868-9; author reply A869-70. PubMed ID: 14644675
    [No Abstract]   [Full Text] [Related]  

  • 36. Trihalomethanes in public water supplies and adverse birth outcomes.
    Dodds L; King W; Woolcott C; Pole J
    Epidemiology; 1999 May; 10(3):233-7. PubMed ID: 10230830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal drugs and the risk of selected birth defects.
    Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
    Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital defects and environmental factors during pregnancy: nationwide surveillance.
    Holmberg PC
    Prog Clin Biol Res; 1985; 163B():287-9. PubMed ID: 3983153
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of selected characteristics of pregnancy drug registries.
    Honein MA; Paulozzi LJ; Cragan JD; Correa A
    Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester exposure to bupropion and risk of cardiac malformations.
    Louik C; Kerr S; Mitchell AA
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.